Global Fragment-based Drug Discovery Market By Product Type (NMR Spectroscopy, DSF Assay) And By End-Users/Application (Biopharmaceutical Companies, CROs) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

Abstract Global Fragment-based Drug Discovery Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Fragment-based Drug Discovery market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. Fragment-based Drug Discovery Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis. By geography, this market has been segregated into five regions with revenue and growth rate of Fragment-based Drug Discovery from 2013 to 2026, • North America (U.S., Canada, Mexico) • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) • Latin America (Brazil, Rest of L.A.) • Middle East And Africa(Turkey, GCC, Rest of Middle East) The major players operating into Fragment-based Drug Discovery Market include: Astex Pharmaceuticals Alveus Pharmaceuticals Pvt. Ltd Beactica AB Charles River Laboratories International, Inc Crown Bioscience, Inc Emerald BioStructures, Inc Evotec AG Kinetic Discovery Limited Proteros Fragments GmbH Sprint Bioscience Structure Based Design, Inc Sygnature Discovery This report segments the Global Fragment-based Drug Discovery Market as follows: Global Fragment-based Drug Discovery Market: Type Segment Analysis NMR Spectroscopy DSF Assay Fluorescence Polarization (FP) Isothermal Titration Calorimetry (ITC) X-ray Crystallography Global Fragment-based Drug Discovery Market: Application Segment Analysis Biopharmaceutical Companies CROs Academic and Research Institutions There are 13 chapters to put on view for Fragment-based Drug Discovery Market: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Fragment-based Drug Discovery Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Fragment-based Drug Discovery Market Overview 1.1.1 Fragment-based Drug Discovery Product Scope 1.1.2 Market Status and Outlook 1.2 Global Fragment-based Drug Discovery Market Size and Analysis by Regions (2014-2019) 1.2.1 North America Fragment-based Drug Discovery Market Status and Outlook 1.2.2 EU Fragment-based Drug Discovery Market Status and Outlook 1.2.3 Japan Fragment-based Drug Discovery Market Status and Outlook 1.2.4 China Fragment-based Drug Discovery Market Status and Outlook 1.2.5 India Fragment-based Drug Discovery Market Status and Outlook 1.2.6 Southeast Asia Fragment-based Drug Discovery Market Status and Outlook 1.3 Global Fragment-based Drug Discovery Market Segment by Types (2014-2025) 1.3.1 Global Fragment-based Drug Discovery Revenue and Growth Rate Comparison by Types (2014-2025) 1.3.2 Global Fragment-based Drug Discovery Revenue Market Share by Types in 2018 1.3.3 NMR Spectroscopy 1.3.4 DSF Assay 1.3.5 Fluorescence Polarization (FP) Others 1.4 Fragment-based Drug Discovery Market by End Users/Application 1.4.1 Global Fragment-based Drug Discovery Revenue (USD Mn) Comparison by Applications (2014-2025) 1.4.1 Biopharmaceutical Companies 1.4.2 CROs 1.4.3 Academic and Research Institutions Others Chapter 2 Global Fragment-based Drug Discovery Competition Analysis by Players 2.1 Global Fragment-based Drug Discovery Market Size (Million USD) by Players (2014-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Astex Pharmaceuticals 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Astex Pharmaceuticals, Fragment-based Drug Discovery Revenue (Million USD) (2014-2019) 3.1.5 Recent Developments 3.2 Alveus Pharmaceuticals Pvt. Ltd 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Alveus Pharmaceuticals Pvt. Ltd, Fragment-based Drug Discovery Revenue (Million USD) (2014-2019) 3.2.5 Recent Developments 3.3 Beactica AB 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Beactica AB, Fragment-based Drug Discovery Revenue (Million USD) (2014-2019) 3.3.5 Recent Developments 3.4 Charles River Laboratories International, Inc 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Charles River Laboratories International, Inc, Fragment-based Drug Discovery Revenue (Million USD) (2014-2019) 3.4.5 Recent Developments 3.5 Crown Bioscience, Inc 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Crown Bioscience, Inc, Fragment-based Drug Discovery Revenue (Million USD)(2014-2019) 3.5.5 Recent Developments 3.6 Emerald BioStructures, Inc 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Emerald BioStructures, Inc, Fragment-based Drug Discovery Revenue (Million USD)(2014-2019) 3.6.5 Recent Developments 3.7 Evotec AG 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Evotec AG, Fragment-based Drug Discovery Revenue (Million USD)(2014-2019) 3.7.5 Recent Developments 3.8 Kinetic Discovery Limited 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Kinetic Discovery Limited, Fragment-based Drug Discovery Revenue (Million USD) (2014-2019) 3.8.5 Recent Developments 3.9 Proteros Fragments GmbH 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Proteros Fragments GmbH, Fragment-based Drug Discovery Revenue (Million USD) (2014-2019) 3.9.5 Recent Developments 3.10 Sprint Bioscience 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Sprint Bioscience, Fragment-based Drug Discovery Revenue (Million USD) (2014-2019) 3.10.5 Recent Developments Chapter 4 Global Fragment-based Drug Discovery Market Size Type (2014-2019) 4.1 Global Fragment-based Drug Discovery Market Size by Type (2014-2019) Chapter 5 Global Fragment-based Drug Discovery Market Size Application (2014-2019) 5.1 Global Fragment-based Drug Discovery Market Size by Application (2014-2019) 5.2 Potential Application of Fragment-based Drug Discovery in Future 5.3 Top Consumer / End Users of Fragment-based Drug Discovery Chapter 6 North America Fragment-based Drug Discovery Development Status and Outlook 6.1 North America Fragment-based Drug Discovery Market Size (2014-2019) 6.2 North America Fragment-based Drug Discovery Market Size by Application (2014-2019) Chapter 7 EU Fragment-based Drug Discovery Development Status and Outlook 7.1 EU Fragment-based Drug Discovery Market Size (2014-2019) 7.2 EU Fragment-based Drug Discovery Market Size by Application (2014-2019) Chapter 8 Japan Fragment-based Drug Discovery Development Status and Outlook 8.1 Japan Fragment-based Drug Discovery Market Size (2014-2019) 8.2 Japan Fragment-based Drug Discovery Market Size by Application (2014-2019) Chapter 9 China Fragment-based Drug Discovery Development Status and Outlook 9.1 China Fragment-based Drug Discovery Market Size and Forecast (2014-2019) 9.2 China Fragment-based Drug Discovery Market Size by Application (2014-2019) Chapter 10 India Fragment-based Drug Discovery Development Status and Outlook 10.1 India Fragment-based Drug Discovery Market Size and Forecast (2014-2019) 10.2 India Fragment-based Drug Discovery Market Size by Application (2014-2019) Chapter 11 Southeast Asia Fragment-based Drug Discovery Development Status and Outlook 11.1 Southeast Asia Fragment-based Drug Discovery Market Size and Forecast (2014-2019) 11.2 Southeast Asia Fragment-based Drug Discovery Market Size by Application (2014-2019) Chapter 12 Market Forecast by Regions and Application (2019-2025) 12.1 Global Fragment-based Drug Discovery Market Size (Million USD) by Regions (2019-2025) 12.1. North America Fragment-based Drug Discovery Revenue and Growth Rate (2019-2025) 12.1.2 EU Fragment-based Drug Discovery Revenue and Growth Rate (2019-2025) 12.1.3 China Fragment-based Drug Discovery Revenue and Growth Rate (2019-2025) 12.1.4 Japan Fragment-based Drug Discovery Revenue and Growth Rate (2019-2025) 12.1.5 Southeast Asia Fragment-based Drug Discovery Revenue and Growth Rate (2019-2025) 12.1.6 India Fragment-based Drug Discovery Revenue and Growth Rate (2019-2025) 12.2 Global Fragment-based Drug Discovery Market Size by Application (2019-2025) Chapter 13 Fragment-based Drug Discovery Market Dynamics 13.1 Fragment-based Drug Discovery Market Opportunities 13.2 Fragment-based Drug Discovery Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Fragment-based Drug Discovery Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Fragment-based Drug Discovery Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
1661

3321

OUR CLIENT